Archive - Aleth

Anthropic opens its books for an IPO

Also this week: OpenAI and Anthropic claim ETH refutations, Gemini 4 Carbon tops the index, Meta plans up to $97.5bn of equity financing & Alphabet…

Oct 31 • Stefan (Stef) Hamill

Formation Bio launches $600m AI drug fund

Also this week: Anthropic’s IPO filing reveals its own drug-discovery lab, Amgen’s Imdelltra cuts lung cancer death risk by 58%, Lilly’s retatrutide…

Oct 30 • Stefan (Stef) Hamill

AI finds a hole in the web’s foundations

Also this week: OpenAI agents weaken monitoring, the US bars DeepSeek, Kimi K3.1 Pro advances & OpenAI seeks $30bn funding at a $1.25tn valuation.

Oct 24 • Stefan (Stef) Hamill

Moderna pulls back on detailed cancer data

Also this week: EQT’s €10.8bn Qiagen deal, GSK’s hepatitis B approval, proposed US biotech investment curbs & Merck KGaA’s $1.3bn Silence deal.

Oct 23 • Stefan (Stef) Hamill

China moves to control frontier AI exports

Also this week: Anthropic reported $16.8bn in quarterly revenue, Meta launched Muse Wonder, Microsoft unveiled its Maia 300 AI chip, and ASML warned AI…

Oct 17 • Stefan (Stef) Hamill

Stryker challenges Intuitive with $400m CMR deal

Also this week: BMS reports two positive phase 3 readouts, EMA backs Rasonque in pancreatic cancer, OMass raises $310m and FDA proposes rare disease…

Oct 16 • Stefan (Stef) Hamill

OpenAI's 700+ preprints cause maths uproar

Also this week: OpenAI put annualised revenue at ~$50bn, Anthropic took evaluations offline after unintended real-world actions and Mistral previewed a…

Oct 10 • Stefan (Stef) Hamill

Halozyme derails Keytruda's European rollout

Also this week: Medicine Nobel Prize awarded to optogenetics pioneers, Biohub and partners commit $1.8bn for AI bio data and Lilly’s Jaypirca wins…

Oct 9 • Stefan (Stef) Hamill

OpenAI shelves GPT-6.1 Astra over deceptive behavior

Also this week: Anthropic's IPO prospectus reported an $8.1bn operating loss, Trump and AI chiefs sign a voluntary accord, the FTC opened a probe into…

Oct 3 • Stefan (Stef) Hamill

AstraZeneca takes $2bn stake in Summit

Also this week: Lilly's EloraTZP cut more weight than Zepbound, Sanofi pays Regeneron $1bn upfront to extend alliance & Novo agrees to license Hengrui's…

Oct 2 • Stefan (Stef) Hamill

September 2026

Xi says AI must stay under human control

Also this week: an OpenAI agent breached Australian Medicare, a US court backs Pentagon’s Anthropic blacklist, the White House asked labs to withhold…

Sep 26 • Stefan (Stef) Hamill

FDA panel backs Grail’s Galleri cancer test

Also this week: Telix agreed to buy ITM for $1.65bn, the White House announced MFN pricing for all 50 state Medicaid programmes, and nine pharma chairs…

Sep 25 • Stefan (Stef) Hamill

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts